Discussion about this post

User's avatar
Florent Beuyet's avatar

I don't sit in the rooms where standing ovations are given to drugs that cure 0 people, add 6 months to life, and cost 477,000 per year — but I counsel the patients who inherit the bill and the toxicity. From the pharmacy counter, 'median six months' stops being a statistic and becomes a person asking me what the hand-foot syndrome is really for, and whether the co-pay math is survivable. The asymmetry that stayed with me from your piece: the drug's value gets tallied in endpoints moved and revenue booked, while the patient pays in dollars and side effects. Pharmacy trains us to quantify value in NNTs and QALYs — then the system prices the marginal month like a cure. Your eulogy-versus-resume distinction holds for medicines, too: a drug's legacy ought to be counted in lives genuinely extended, not in progression-free survival gains that never became time anyone actually got to live.

T Kevin Rice's avatar

I didn’t see this one coming

Posts like this are why I stay on this app

We’re tasked with impossible situations to deal with day in and out

Humanism is never the wrong choice

Thanks for the reminder

(I hope I spaced this properly lol)

66 more comments...

Ready for more?